{
  "docId": "019de514-cbd7-74b0-bf8d-aa9d6e0855ea",
  "docSlug": "3978f49804712c50e1386551925a824d",
  "documentTitle": "Avantor | Investor Conference Presentation Deck | 22 slides",
  "authorId": "avantor",
  "authorName": "Avantor",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-01-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 10,
  "pageCount": 22,
  "prevPage": 9,
  "nextPage": 11,
  "slideType": "before_after",
  "function": "frame_situation",
  "density": "dense",
  "nDataPoints": 9,
  "notes": null,
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de514-cbd7-74b0-bf8d-aa9d6e0855ea/10",
  "deckHref": "/decks/019de514-cbd7-74b0-bf8d-aa9d6e0855ea",
  "deckJsonHref": "/decks/019de514-cbd7-74b0-bf8d-aa9d6e0855ea.json",
  "deckAnchorHref": "/decks/019de514-cbd7-74b0-bf8d-aa9d6e0855ea#slide-10",
  "components": [
    {
      "bbox": {
        "h": 0.56,
        "w": 0.34,
        "x": 0.62,
        "y": 0.18
      },
      "kind": "image",
      "text": "Image of a person in a cleanroom suit with a 4X growth in bioproduction revenue callout.",
      "attrs": {},
      "subkind": "photo",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "051193ab-f7ce-4f2e-9aab-2250be8945cf",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.4,
        "x": 0.22,
        "y": 0.87
      },
      "kind": "source-note",
      "text": "1. Legacy refers to: organic lab growth - average organic revenue growth of legacy VWR from 2010 - 2017, bioproduction customers - legacy Avantor bioproduction customers in 2017, presence in top 20 biologic drugs - legacy Avantor presence in 2017 from Evaluate Pharma. 2. Avantor refers to: organic lab growth - data of combined entity from 2018-2022E, bioproduction customers - combined entity in 2022E, presence in top 20 biologic drugs - combined entity presence in 2022 from Evaluate Pharma. 3. Comparing legacy Avantor bioproduction sales in 2017 vs. 2022E bioproduction sales.",
      "attrs": {},
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "b4980c78-21a7-45fa-82f4-a089a1b9d941",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.01,
        "w": 0.29,
        "x": 0.65,
        "y": 0.94
      },
      "kind": "source-note",
      "text": "41st Annual J.P. Morgan Healthcare Conference",
      "attrs": {},
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "ff6688fc-62bc-4cc6-a946-b239f3890a2b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.6,
        "w": 0.58,
        "x": 0.039,
        "y": 0.18
      },
      "kind": "table",
      "text": "Organic lab growth: Legacy 2-3%, Avantor 4-5%. Bioproduction customers: Legacy ~2,000, Avantor ~9,000. Presence in top 20 biologic drugs: Legacy ~80%, Avantor ~85%.",
      "attrs": {},
      "subkind": "data",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "35c6b10a-eba4-42ea-a808-7a2379fcdf9a",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.63,
        "x": 0.039,
        "y": 0.06
      },
      "kind": "title",
      "text": "Combined platform is stronger than ever",
      "attrs": {},
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "bce45a3b-7186-4205-9429-61e8c87f4efd",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 14,
      "from": 10,
      "beatId": "a4cc6a37-b241-4892-88e4-ed0392929e27",
      "arcName": "The Sequoia Pitch",
      "arcSlug": "sequoia-pitch",
      "beatName": "Solution",
      "beatSlug": "sequoia-pitch-solution",
      "evidence": "Slides 10-14: Combined platform is stronger than ever, Embedding ESG practices across our business, Innovation enhances growth and resilience, and Expansion supports growth engine",
      "position": 3,
      "confidence": 0.8,
      "parentBeatName": "Turn",
      "parentBeatSlug": "turn"
    }
  ],
  "loops": [
    {
      "to": 10,
      "from": 10,
      "name": "Before After",
      "slug": "21-before-after",
      "bestFor": "Product demos, process improvements, ROI justification",
      "matchId": "39afe4be-926b-4e4f-a1ab-02539460cfb9",
      "evidence": "Slide 10: Combined platform is stronger than ever",
      "position": 0,
      "objective": "Highlight the strength of the combined platform",
      "structure": "The Old Way (Pain) -> The Moment of Change -> The New Way (Glory) -> The Measurable Delta",
      "confidence": 0.8,
      "description": "Show the dramatic contrast between the old way and the new way through side-by-side comparison"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}